GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Modeyso® | ONC-201 | ONC201 | TIC-10 | TIC10
dordaviprone is an approved drug
Compound class:
Synthetic organic
Comment: Dordaviprone (ONC201, also known as TIC10 [2]) was originally discovered as a TRAIL pathway inducer and as an orally active dual Akt/ERK inhibitor [1]. It exerts potent anti-tumour effects [7,11-12].
ONC201 was later reported as an allosteric activator of the oncology drug target, mitochondrial protease caseinolytic protease P (ClpP) [5-6,10]. It also antagonises dopamine D2/3 receptor signalling [8-9]. |
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| ONC201 has anti-proliferative and pro-apoptotic effects that are mediated (at least in part) by activation of the integrated stress response [13], and upregulation of natural anti-tumour immune surveillance. |
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||